HEAL vs. BBC
HEAL (Global X HealthTech ETF) and BBC (Virtus LifeSci Biotech Clinical Trials ETF) are both Health & Biotech Equities funds - HEAL tracks the Global X HealthTech Index while BBC tracks the LifeSci Biotechnology Clinical Trials Index. Both are passively managed. Over the past 5 years, HEAL returned -14.71%/yr vs -1.96%/yr for BBC. A 0.64 correlation means they provide meaningful diversification when combined. HEAL charges 0.50%/yr vs 0.79%/yr for BBC.
Performance
HEAL vs. BBC - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HEAL achieves a -15.57% return, which is significantly lower than BBC's 8.64% return.
HEAL
- 1D
- -1.16%
- 1M
- -2.59%
- YTD
- -15.57%
- 6M
- -20.78%
- 1Y
- -22.08%
- 3Y*
- -10.46%
- 5Y*
- -14.71%
- 10Y*
- —
BBC
- 1D
- 0.43%
- 1M
- -6.52%
- YTD
- 8.64%
- 6M
- 14.08%
- 1Y
- 116.78%
- 3Y*
- 19.99%
- 5Y*
- -1.96%
- 10Y*
- 7.64%
HEAL vs. BBC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HEAL Global X HealthTech ETF | -15.57% | -0.62% | -2.87% | -12.61% | -29.99% | -14.21% | 23.87% |
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.64% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 24.21% |
Correlation
The correlation between HEAL and BBC is 0.49, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.49 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.55 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.63 |
Correlation (All Time) Calculated using the full available price history since Jul 31, 2020 | 0.64 |
The correlation between HEAL and BBC shifts across timeframes, from 0.49 (1 year) to 0.64 (all time), reflecting how their relationship changes across market environments.
HEAL vs. BBC - Sectors Allocation Comparison
Sectors
HEAL
BBC
Healthcare
Technology
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Utilities
-
-
Healthcare
HEAL
BBC
Technology
HEAL
BBC
-
Basic Materials
HEAL
-
BBC
-
Communication Services
HEAL
-
BBC
-
Consumer Cyclical
HEAL
-
BBC
-
Consumer Defensive
HEAL
-
BBC
-
Energy
HEAL
-
BBC
-
Financial Services
HEAL
-
BBC
-
Industrials
HEAL
-
BBC
-
Real Estate
HEAL
-
BBC
-
Utilities
HEAL
-
BBC
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HEAL vs. BBC — Risk / Return Rank
HEAL
BBC
HEAL vs. BBC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Global X HealthTech ETF (HEAL) and Virtus LifeSci Biotech Clinical Trials ETF (BBC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HEAL | BBC | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -4.33 | ||
| Sortino ratioReturn per unit of downside risk | -5.38 | ||
| Omega ratioGain probability vs. loss probability | 0.85 | 1.46 | -0.61 |
| Calmar ratioReturn relative to maximum drawdown | -0.72 | 7.78 | -8.50 |
| Martin ratioReturn relative to average drawdown | -1.46 | 24.80 | -26.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HEAL | BBC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.01 | 3.32 | -4.33 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.56 | -0.05 | -0.51 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.20 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.39 | 0.12 | -0.51 |
Drawdowns
HEAL vs. BBC - Drawdown Comparison
The maximum HEAL drawdown since its inception was -65.76%, smaller than the maximum BBC drawdown of -76.85%. Use the drawdown chart below to compare losses from any high point for HEAL and BBC.
Loading charts...
Drawdown Indicators
| HEAL | BBC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -65.76% | -76.85% | +11.09% |
Max Drawdown (1Y)Largest decline over 1 year | -30.71% | -15.10% | -15.61% |
Max Drawdown (3Y)Largest decline over 3 years | -35.78% | -54.45% | +18.67% |
Max Drawdown (5Y)Largest decline over 5 years | -60.36% | -72.44% | +12.08% |
Max Drawdown (10Y)Largest decline over 10 years | — | -76.85% | — |
Current DrawdownCurrent decline from peak | -63.55% | -30.27% | -33.28% |
Average DrawdownAverage peak-to-trough decline | -43.02% | -37.14% | -5.88% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 15.13% | 4.73% | +10.40% |
Volatility
HEAL vs. BBC - Volatility Comparison
The current volatility for Global X HealthTech ETF (HEAL) is 5.21%, while Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a volatility of 10.93%. This indicates that HEAL experiences smaller price fluctuations and is considered to be less risky than BBC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HEAL | BBC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.21% | 10.93% | -5.72% |
Volatility (6M)Calculated over the trailing 6-month period | 15.69% | 26.43% | -10.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.89% | 35.50% | -13.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 26.37% | 39.31% | -12.94% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 26.18% | 37.74% | -11.56% |
HEAL vs. BBC - Expense Ratio Comparison
HEAL has a 0.50% expense ratio, which is lower than BBC's 0.79% expense ratio.
Dividends
HEAL vs. BBC - Dividend Comparison
HEAL's dividend yield for the trailing twelve months is around 0.39%, less than BBC's 1.56% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.56% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
HEAL Global X HealthTech ETF | 0.39% | 0.33% | 0.00% | 0.00% | 0.00% | 0.00% | 0.03% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
HEAL and BBC have a correlation of 0.49, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (10.93%) compared to HEAL (5.21%). In terms of maximum drawdown, HEAL dropped -65.76% vs BBC's -76.85%.
On 5-year performance, BBC leads with -1.96% vs -14.71% for HEAL. On fees, HEAL is cheaper at 0.50% per year. On volatility, HEAL has been the lower-risk option at 5.21%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, BBC has performed better with a -1.96% return vs -14.71%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
HEAL is cheaper with a 0.50% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.56%, compared with 0.39% for HEAL.
HEAL tracks Global X HealthTech Index, while BBC tracks LifeSci Biotechnology Clinical Trials Index. They also come from different issuers: Global X and Virtus Investment Partners. Their fees differ too: 0.50% for HEAL and 0.79% for BBC.
BBC currently has the higher Sharpe Ratio (3.32 vs -1.01), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HEAL and BBC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer